Education
About Us
Working with TipRanks
Follow Us
N4 Pharma PLC (GB:N4P)
LSE:N4P
N4P Stock Chart & Stats
0.60p
<0.01p(0.80%)
At close: 4:00 PM EST
0.60p
<0.01p(0.80%)
Day’s Range― - ―
52-Week Range0.35p - 1.00p
Previous CloseN/A
Volume555.10K
Average Volume (3M)552.75K
Market Cap
£4.58M
Enterprise Value3.27M
Total Cash (Recent Filing)£1.73M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.82
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding832,280,330
10 Day Avg. Volume400,768
30 Day Avg. Volume552,755
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)2.76
Price to Sales (P/S)245.40
P/FCF Ratio-1.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
N4 Pharma News
N4P FAQ
What was N4 Pharma PLC’s price range in the past 12 months?
N4 Pharma PLC lowest share price was 0.35p and its highest was 1.00p in the past 12 months.
What is N4 Pharma PLC’s market cap?
N4 Pharma PLC’s market cap is £4.58M.
When is N4 Pharma PLC’s upcoming earnings report date?
N4 Pharma PLC’s upcoming earnings report date is Sep 24, 2026 which is in 208 days.
How were N4 Pharma PLC’s earnings last quarter?
Currently, no data Available
Is N4 Pharma PLC overvalued?
According to Wall Street analysts N4 Pharma PLC’s price is currently Overvalued.
Does N4 Pharma PLC pay dividends?
N4 Pharma PLC does not currently pay dividends.
What is N4 Pharma PLC’s EPS estimate?
N4 Pharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does N4 Pharma PLC have?
N4 Pharma PLC has 832,280,330 shares outstanding.
What happened to N4 Pharma PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of N4 Pharma PLC?
Currently, no hedge funds are holding shares in GB:N4P
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
N4 Pharma PLC
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Technical Analysis
Eco Animal Health
―
Chill Brands Group PLC
―
Mountfield
―
Provexis
―
Shield Therapeutics
―